OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: Foundation for the National Institutes of Health, Inc.

13 Projects | 10 Researchers | $1,572,000 Invested

2021

Foundation for the National Institutes of Health, Inc.

Wesley Horton

Neurofilament (Nf) as a Fluid Biomarker of Neurodegeneration in Familial Frontotemporal Degeneration (f-FTD)

  • Funding Amount: $280,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: Neuronal Degeneration
  • Status: Active

2020

Foundation for the National Institutes of Health, Inc.

Wesley Horton

Pre-competitive Analytical Validation of SV2A PET as a Biomarker of Synaptic Density Project

  • Funding Amount: $300,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Active

2020

Foundation for the National Institutes of Health, Inc.

Wesley Horton

Plasma Aβ as a Predictor of Amyloid Positivity in Alzheimer’s Disease

  • Funding Amount: $402,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: zzAbeta
  • Status: Active

2019

Foundation for the National Institutes of Health, Inc.

Kelly Umana

Alzheimer's Disease Neuroimaging Initiative (ADNI) 3 - Amyloid PET Early Frames Add-on Study

  • Funding Amount: $75,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: zzNeuroimaging and Functional Activity Measures
  • Status: Active

2018

Foundation for the National Institutes of Health, Inc.

Meredith Upton

Inflammatory Markers for Early Detection & Subtyping of Neurodegenerative & Mood Disorders

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: Neuroinflammation
  • Status: Active

2018

Foundation for the National Institutes of Health, Inc.

Joe Menetski, PhD

Alzheimer's Disease Neuroimaging Initiative (ADNI) 3

  • Funding Amount: $50,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: zzNeuroimaging and Functional Activity Measures
  • Status: Closed

2018

Foundation for the National Institutes of Health, Inc.

Alison Drone, MA

Alzheimer's Disease Research Summit 2018 Sponsorship

  • Funding Amount: $5,000
  • Organization Type: Academic/Nonprofit
  • Program: Conferences/Other
  • Target: Other
  • Status: Closed

2015

Foundation for the National Institutes of Health, Inc.

Renee Bullion, MPA

2015 Alzheimer's Disease Research Summit

  • Funding Amount: $5,000
  • Organization Type: Academic/Nonprofit
  • Program: Conferences/Other
  • Status: Closed

2014

Foundation for the National Institutes of Health, Inc.

David Wholley, MA

Accelerating Medicines Partnership (AMP) - Alzheimer's Disease formerly the Target Validation Consortium (TVC)

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2010

Foundation for the National Institutes of Health, Inc.

Michael Weiner, MD

Alzheimer's Disease Neuroimaging Initiative (ADNI)

  • Funding Amount: $50,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed
View More